GENUS BIOSYSTEMS INC

Genus Biosystems Inc. specializes in advanced molecular diagnostics and genomic analysis services, with a focus on high-throughput laboratory testing for biomedical research and clinical applications. Their core capabilities include mRNA and microRNA microarray profiling, precision biomarker discovery, and radiation therapy outcome prediction modeling using next-generation genomic technologies. The company leverages cutting-edge nucleic acid detection platforms and bioinformatics pipelines to deliver data-driven insights for therapeutic efficacy assessment, distinguishing itself through expertise in translational genomics and RNA-based diagnostic development. Their work supports evidence-based decision-making in oncology and radiation oncology, with a strong emphasis on reproducible, clinically validated analytical methods. The contractor maintains a focused relationship with the Department of Health and Human Services, delivering specialized laboratory testing services that support public health research and personalized medicine initiatives. Their engagements center on genomic profiling for therapeutic response prediction, indicating a trusted role in supporting HHS-funded biomedical studies requiring rigorous molecular characterization. Genus Biosystems operates primarily within the Testing Laboratories and Services (NAICS 541380) sector, positioning itself as a niche provider of molecular diagnostics for biomedical research applications. Their market focus is on precision health technologies, particularly in the intersection of genomics, radiation biology, and predictive analytics, serving government-funded research programs that demand high-complexity clinical laboratory services. As a small business structured as a 2L entity headquartered in Northbrook, Illinois, Genus Biosystems Inc. is a specialized provider with no federal certifications on record. Their geographic presence is centered in the Midwest, with a targeted government market footprint focused on health and biomedical research contracting. The company’s operational model emphasizes technical precision and scientific rigor in supporting federal research objectives through specialized laboratory services.